A detailed history of Stifel Financial Corp transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Stifel Financial Corp holds 142,075 shares of JAZZ stock, worth $17.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
142,075
Previous 121,400 17.03%
Holding current value
$17.4 Million
Previous $13 Million 22.21%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $2.08 Million - $2.41 Million
20,675 Added 17.03%
142,075 $15.8 Million
Q2 2024

Aug 13, 2024

BUY
$103.94 - $118.98 $1.24 Million - $1.42 Million
11,938 Added 10.91%
121,400 $13 Million
Q1 2024

May 13, 2024

BUY
$115.19 - $132.77 $6.63 Million - $7.64 Million
57,555 Added 110.88%
109,462 $13.2 Million
Q4 2023

Feb 12, 2024

SELL
$114.26 - $136.0 $1.73 Million - $2.06 Million
-15,182 Reduced 22.63%
51,907 $6.38 Million
Q3 2023

Nov 13, 2023

BUY
$122.0 - $145.31 $419,680 - $499,866
3,440 Added 5.4%
67,089 $8.68 Million
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $1.45 Million - $1.74 Million
11,841 Added 22.86%
63,649 $7.89 Million
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $381,441 - $456,858
2,847 Added 5.81%
51,808 $7.58 Million
Q4 2022

Feb 13, 2023

BUY
$129.72 - $159.85 $261,515 - $322,257
2,016 Added 4.29%
48,961 $7.8 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $1.58 Million - $2.01 Million
12,476 Added 36.19%
46,945 $6.26 Million
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $782,851 - $932,521
5,529 Added 19.11%
34,469 $5.38 Million
Q1 2022

May 13, 2022

BUY
$129.64 - $160.7 $786,136 - $974,484
6,064 Added 26.51%
28,940 $4.51 Million
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $828,421 - $1.01 Million
-6,911 Reduced 23.2%
22,876 $2.92 Million
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $424,769 - $610,176
3,302 Added 12.47%
29,787 $3.88 Million
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $1.14 Million - $1.33 Million
7,132 Added 36.85%
26,485 $4.71 Million
Q1 2021

May 14, 2021

BUY
$150.19 - $173.5 $961,366 - $1.11 Million
6,401 Added 49.42%
19,353 $3.18 Million
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $61,630 - $72,291
-438 Reduced 3.27%
12,952 $2.14 Million
Q3 2020

Nov 16, 2020

BUY
$105.46 - $144.13 $276,621 - $378,052
2,623 Added 24.36%
13,390 $1.91 Million
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $211,548 - $269,476
2,211 Added 25.84%
10,767 $1.19 Million
Q1 2020

May 14, 2020

SELL
$87.74 - $152.74 $2.4 Million - $4.17 Million
-27,317 Reduced 76.15%
8,556 $847,000
Q4 2019

Feb 13, 2020

SELL
$117.65 - $153.73 $316,007 - $412,918
-2,686 Reduced 6.97%
35,873 $5.33 Million
Q3 2019

Nov 19, 2019

BUY
$125.18 - $143.24 $876 - $1,002
7 Added 0.02%
38,559 $4.93 Million
Q3 2019

Nov 13, 2019

BUY
$125.18 - $143.24 $18,526 - $21,199
148 Added 0.39%
38,552 $4.93 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $189,078 - $217,586
1,506 Added 4.08%
38,404 $5.48 Million
Q1 2019

May 14, 2019

BUY
$121.81 - $142.95 $1.37 Million - $1.6 Million
11,226 Added 43.73%
36,898 $5.27 Million
Q4 2018

Feb 13, 2019

SELL
$115.94 - $166.74 $186,199 - $267,784
-1,606 Reduced 5.89%
25,672 $3.16 Million
Q3 2018

Nov 13, 2018

BUY
$161.01 - $180.57 $484,801 - $543,696
3,011 Added 12.41%
27,278 $4.6 Million
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $498,399 - $623,911
3,406 Added 16.33%
24,267 $4.18 Million
Q1 2018

May 11, 2018

BUY
$135.59 - $157.16 $341,415 - $395,728
2,518 Added 13.73%
20,861 $3.16 Million
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $1.1 Million - $1.27 Million
-8,413 Reduced 31.44%
18,343 $2.45 Million
Q3 2017

Nov 13, 2017

BUY
$142.62 - $155.6 $3.82 Million - $4.16 Million
26,756
26,756 $0

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.68B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.